Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Salmon

Showing results (41-50 of 219) with videos related to

Pageof 22
Sort By:
Neuropsychology|April 4, 2007
Implicit category learning performance predicts rate of cognitive decline in nondemented patients with Parkinson's diseaseJ Vincent Filoteo, W Todd Maddox, David P Salmon, et al.
Journal of the International Neuropsychological Society : JINS|February 3, 2005
Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotationTara T Lineweaver, David P Salmon, Mark W Bondi, et al.
Neurology|July 20, 2019
Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic featuresYuqi Qiu, Diane M Jacobs, Karen Messer, et al.
Neurology|March 16, 2021
Age-at-Onset and <i>APOE</i>-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer DiseaseDenis S Smirnov, Douglas Galasko, Annie Hiniker, et al.
Neuropsychology|January 5, 2007
Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's diseaseKatya Rascovsky, David P Salmon, Lawrence A Hansen, et al.
International Journal of Statistics in Medical Research|March 15, 2024
Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical TrialsXinran Wang, Diane Jacobs, David P Salmon, et al.
Alzheimer Disease and Associated Disorders|August 19, 2006
Robert Katzman honoredLeon J Thal, Claudia Kawas, Douglas Galasko, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2013
The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's diseaseMicaela Mitolo, David P Salmon, Simona Gardini, et al.
Journal of Clinical and Experimental Neuropsychology|January 12, 2019
Alzheimer's disease and the processing of uncertainty during choice task performance: Executive dysfunction within the Hick-Hyman lawLaura E Korthauer, David P Salmon, Elena K Festa, et al.
Journal of the International Neuropsychological Society : JINS|November 25, 2003
The myth of testing construct validity using factor analysis or correlations with normal or mixed clinical populations: lessons from memory assessmentDean C Delis, Mark Jacobson, Mark W Bondi, et al.
Pageof 22

Showing results (41-50 of 219) with videos related to

Sort By:
Pageof 22
Neuropsychology|April 4, 2007
Implicit category learning performance predicts rate of cognitive decline in nondemented patients with Parkinson's diseaseJ Vincent Filoteo, W Todd Maddox, David P Salmon, et al.
Journal of the International Neuropsychological Society : JINS|February 3, 2005
Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotationTara T Lineweaver, David P Salmon, Mark W Bondi, et al.
Neurology|July 20, 2019
Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic featuresYuqi Qiu, Diane M Jacobs, Karen Messer, et al.
Neurology|March 16, 2021
Age-at-Onset and <i>APOE</i>-Related Heterogeneity in Pathologically Confirmed Sporadic Alzheimer DiseaseDenis S Smirnov, Douglas Galasko, Annie Hiniker, et al.
Neuropsychology|January 5, 2007
Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's diseaseKatya Rascovsky, David P Salmon, Lawrence A Hansen, et al.
International Journal of Statistics in Medical Research|March 15, 2024
Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical TrialsXinran Wang, Diane Jacobs, David P Salmon, et al.
Alzheimer Disease and Associated Disorders|August 19, 2006
Robert Katzman honoredLeon J Thal, Claudia Kawas, Douglas Galasko, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2013
The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's diseaseMicaela Mitolo, David P Salmon, Simona Gardini, et al.
Journal of Clinical and Experimental Neuropsychology|January 12, 2019
Alzheimer's disease and the processing of uncertainty during choice task performance: Executive dysfunction within the Hick-Hyman lawLaura E Korthauer, David P Salmon, Elena K Festa, et al.
Journal of the International Neuropsychological Society : JINS|November 25, 2003
The myth of testing construct validity using factor analysis or correlations with normal or mixed clinical populations: lessons from memory assessmentDean C Delis, Mark Jacobson, Mark W Bondi, et al.
Pageof 22